当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 现金流量表

康泰医学

(300869)

  

流通市值:41.88亿  总市值:66.42亿
流通股本:2.53亿   总股本:4.02亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金361,874,584.12232,338,810.43125,886,621.02491,576,488.76
  收到的税费返还8,639,820.675,543,420.954,454,714.926,320,508.23
  收到其他与经营活动有关的现金17,941,846.6911,060,774.326,641,199.0828,399,583.83
  经营活动现金流入小计388,456,251.48248,943,005.7136,982,535.02526,296,580.82
  购买商品、接受劳务支付的现金133,084,073.5581,881,272.8641,095,929.38120,318,419.64
  支付给职工以及为职工支付的现金131,325,164.2584,973,934.1941,875,623.95185,056,347.55
  支付的各项税费20,316,927.2510,183,845.014,243,316.6547,005,510.6
  支付其他与经营活动有关的现金84,129,192.8646,008,502.4819,819,821.5111,573,724.21
  经营活动现金流出小计368,855,357.91223,047,554.54107,034,691.48463,954,002
  经营活动产生的现金流量净额19,600,893.5725,895,451.1629,947,843.5462,342,578.82
二、投资活动产生的现金流量:
  收回投资收到的现金490,000,000230,000,0002,117,852,634.845,250,064,143.6
  取得投资收益收到的现金22,026,863.8511,087,403.345,901,591.18118,076,646.82
  处置固定资产、无形资产和其他长期资产收回的现金净额32,000--947,103.01
  收到的其他与投资活动有关的现金2,472,924,300.242,265,405,327.8630,000,000-
  投资活动现金流入小计2,984,983,164.092,506,492,731.22,153,754,226.025,369,087,893.43
  购建固定资产、无形资产和其他长期资产支付的现金32,769,079.822,949,291.245,030,122.7254,460,712.53
  投资支付的现金950,000,000700,000,0002,167,741,055.885,150,304,023.84
  支付其他与投资活动有关的现金1,968,008,573.241,770,409,523.84-270,000,000
  投资活动现金流出小计2,950,777,653.042,493,358,815.082,172,771,178.65,474,764,736.37
  投资活动产生的现金流量净额34,205,511.0513,133,916.12-19,016,952.58-105,676,842.94
三、筹资活动产生的现金流量:
  取得借款收到的现金227,000,000165,000,00031,436,896.3790,000,000
  收到其他与筹资活动有关的现金22,010,00022,010,00022,010,000673,187,600
  筹资活动现金流入小计249,010,000187,010,00053,446,896.37763,187,600
  偿还债务支付的现金90,000,00060,000,000-377,000,000
  分配股利、利润或偿付利息支付的现金110,878,192.68101,568,436480,483.33127,716,768.46
  支付其他与筹资活动有关的现金1,394,382.229,519,302.1482,710.982,209,831.26
  筹资活动现金流出小计202,272,574.9171,087,738.1963,194.31506,926,599.72
  筹资活动产生的现金流量净额46,737,425.115,922,261.952,483,702.06256,261,000.28
四、汇率变动对现金及现金等价物的影响-6,992,635.8-1,792,124.01-339,893.734,157,788.59
五、现金及现金等价物净增加额93,551,193.9253,159,505.1763,074,699.29217,084,524.75
  加:期初现金及现金等价物余额684,307,771.48684,307,771.48684,307,771.48467,223,246.73
  期末现金及现金等价物余额777,858,965.4737,467,276.65747,382,470.77684,307,771.48
补充资料:
  净利润-16,937,573.17--77,902,564.68
  资产减值准备-16,022,591.5-109,445,716.65
  固定资产和投资性房地产折旧-11,631,377.86-23,634,386.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,612,176.19-22,178,035.08
    投资性房地产折旧-2,019,201.67-1,456,351.1
  无形资产摊销-1,179,849.12-2,353,178.8
  长期待摊费用摊销-40,943.76-15,844.08
  递延收益摊销--393,676.33--1,395,476.07
  处置固定资产、无形资产和其他长期资产的损失-11,244.08-88,681.75
  固定资产报废损失-0--
  公允价值变动损失--2,752,724.31--1,588,083.19
  财务费用-4,117,441.13--2,805,002.07
  投资损失--849,480.1--22,518,834.81
  递延所得税--1,393,102.02-2,171,474.51
  其中:递延所得税资产减少--1,298,322.66-2,025,191.54
    递延所得税负债增加--94,779.36-146,282.97
  存货的减少--21,974,341.72-74,032,834.19
  经营性应收项目的减少--7,860,342--13,877,282.67
  经营性应付项目的增加-10,329,532.41--33,092,145.64
  其他---0
  现金的期末余额-737,467,276.65-684,307,771.48
  减:现金的期初余额-684,307,771.48--
  减:现金等价物的期初余额---467,223,246.73
  现金及现金等价物的净增加额-53,159,505.17-217,084,524.75
公告日期2025-10-302025-08-292025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑